Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | EClinicalMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537024005583 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832591775763529728 |
---|---|
author | Alizée Bozonnat Marie Beylot-Barry Olivier Dereure Michel D’Incan Gaëlle Quereux Emmanuella Guenova Marie Perier-Muzet Stephane Dalle Florent Grange Manuelle-Anne Viguier Caroline Ram-Wolff Laurence Feldmeyer Helmut Beltraminelli Nathalie Bonnet Florent Amatore Eve Maubec Nathalie Franck Laurent Machet François Chasset Florence Brunet-Possenti Jean-David Bouaziz Maxime Battistella Marie Donzel Anne Pham-Ledard Claudia Bejar Hélène Moins-Teisserenc Samia Mourah Philippe Saiag Ewa Hainaut Catherine Michel Guido Bens Henri Adamski François Aubin Serge Boulinguez Pascal Joly Billal Tedbirt Isabelle Templier Laura Troin Henri Montaudié Saskia Ingen-Housz-Oro Sarah Faiz Laurent Mortier Gabor Dobos Martine Bagot Matthieu Resche-Rigon Claire Montlahuc Arnaud Serret-Larmande Adèle de Masson |
author_facet | Alizée Bozonnat Marie Beylot-Barry Olivier Dereure Michel D’Incan Gaëlle Quereux Emmanuella Guenova Marie Perier-Muzet Stephane Dalle Florent Grange Manuelle-Anne Viguier Caroline Ram-Wolff Laurence Feldmeyer Helmut Beltraminelli Nathalie Bonnet Florent Amatore Eve Maubec Nathalie Franck Laurent Machet François Chasset Florence Brunet-Possenti Jean-David Bouaziz Maxime Battistella Marie Donzel Anne Pham-Ledard Claudia Bejar Hélène Moins-Teisserenc Samia Mourah Philippe Saiag Ewa Hainaut Catherine Michel Guido Bens Henri Adamski François Aubin Serge Boulinguez Pascal Joly Billal Tedbirt Isabelle Templier Laura Troin Henri Montaudié Saskia Ingen-Housz-Oro Sarah Faiz Laurent Mortier Gabor Dobos Martine Bagot Matthieu Resche-Rigon Claire Montlahuc Arnaud Serret-Larmande Adèle de Masson |
author_sort | Alizée Bozonnat |
collection | DOAJ |
format | Article |
id | doaj-art-73770a100c944ed8a8857a7a8f8a4f3a |
institution | Kabale University |
issn | 2589-5370 |
language | English |
publishDate | 2025-01-01 |
publisher | Elsevier |
record_format | Article |
series | EClinicalMedicine |
spelling | doaj-art-73770a100c944ed8a8857a7a8f8a4f3a2025-01-22T05:43:14ZengElsevierEClinicalMedicine2589-53702025-01-0179102979Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort studyAlizée Bozonnat0Marie Beylot-Barry1Olivier Dereure2Michel D’Incan3Gaëlle Quereux4Emmanuella Guenova5Marie Perier-Muzet6Stephane Dalle7Florent Grange8Manuelle-Anne Viguier9Caroline Ram-Wolff10Laurence Feldmeyer11Helmut Beltraminelli12Nathalie Bonnet13Florent Amatore14Eve Maubec15Nathalie Franck16Laurent Machet17François Chasset18Florence Brunet-Possenti19Jean-David Bouaziz20Maxime Battistella21Marie Donzel22Anne Pham-Ledard23Claudia Bejar24Hélène Moins-Teisserenc25Samia Mourah26Philippe Saiag27Ewa Hainaut28Catherine Michel29Guido Bens30Henri Adamski31François Aubin32Serge Boulinguez33Pascal Joly34Billal Tedbirt35Isabelle Templier36Laura Troin37Henri Montaudié38Saskia Ingen-Housz-Oro39Sarah Faiz40Laurent Mortier41Gabor Dobos42Martine Bagot43Matthieu Resche-Rigon44Claire Montlahuc45Arnaud Serret-Larmande46Adèle de Masson47Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France; INSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, FranceDepartment of Dermatology, CHU de Bordeaux, BoRdeaux Institute of Oncology, BRIC INSERM U1312, INSERM BoRdeaux Institute of Oncology, Team 5, Université de Bordeaux, Bordeaux, FranceDepartment of Dermatology, University of Montpellier, Montpellier, FranceDepartment of Dermatology, CHU de Clermont-Ferrand, Clermont-Ferrand, FranceDepartment of Dermatology, Nantes University Hospital, CIC 1413, Inserm UMR 1302/EMR6001 INCIT, F-44000 Nantes, FranceDepartment of Dermatology, University Hospital Lausanne, Faculty of Biology and Medicine, University of Lausanne, Lausanne, SwitzerlandDepartment of Dermatology, Hospices Civils de Lyon, Lyon, FranceDepartment of Dermatology, Hospices Civils de Lyon, Lyon, FranceDepartment of Dermatology, CH de Valence, FranceDepartment of Dermatology, Université Reims-Champagne Ardenne, EA7509-IRMAIC, Reims, FranceDepartment of Dermatology, Saint-Louis Hospital, AP-HP, Paris, FranceDepartment of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandDepartment of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandDepartment of Dermatology, CHU de Marseille, Marseille, FranceDepartment of Dermatology, CHU de Marseille, Marseille, FranceDepartment of Dermatology, Avicenne Hospital, AP-HP, Bobigny, FranceDepartment of Dermatology, CHU Cochin, Paris, FranceDepartment of Dermatology, CHU de Tours, Tours, FranceDepartment of Dermatology, CHU Tenon, Faculty of Medicine, Sorbonne University, Paris, FranceDepartment of Dermatology, CHU Bichat, Paris, FranceDepartment of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France; INSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, FranceINSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, France; Pathology Laboratory, Saint-Louis Hospital, AP-HP, Paris, FrancePathology Laboratory, Hospices Civils de Lyon, Lyon, FranceDepartment of Dermatology, CHU de Bordeaux, BoRdeaux Institute of Oncology, BRIC INSERM U1312, INSERM BoRdeaux Institute of Oncology, Team 5, Université de Bordeaux, Bordeaux, FranceDepartment of Dermatology, Avicenne Hospital, AP-HP, Bobigny, FranceUniversité Paris Cité, Paris, France; Hematology Laboratory, Saint-Louis Hospital, AP-HP, Paris, FranceINSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, France; Department of Pharmacogenomics and Oncogenetics, Saint-Louis Hospital, AP-HP, Paris, FranceDepartment of Dermatology, Ambroise-Paré Hospital, AP-HP, & EA 4340 “Biomarkers in Cancerology and Hemato-Oncology”, UVSQ, Université Paris-Saclay, 92104, Boulogne-Billancourt, FranceDepartment of Dermatology, CHU de Poitiers, Poitiers, FranceDepartment of Dermatology, CH Mulhouse, Groupe Hospitalier Mulhouse Sud Alsace, Mulhouse, FranceDepartment of Dermatology, CHU Orléans, Orléans, FranceDepartment of Dermatology, CHU Pontchaillou, Rennes, FranceDepartment of Dermatology, CHU de Besançon, Besançon, FranceDepartment of Dermatology, CHU de Toulouse, Toulouse, FranceDepartment of Dermatology, CHU de Rouen, Rouen, FranceDepartment of Dermatology, CHU de Rouen, Rouen, FranceDepartment of Dermatology, CHU de Grenoble, Grenoble, FranceDepartment of Dermatology, CHU de Nice, Nice, FranceDepartment of Dermatology, CHU de Nice, Nice, FranceDepartment of Dermatology, Henri Mondor Hospital, APHP, Créteil, FranceDepartment of Dermatology, CHU Lille, Lille, FranceDepartment of Dermatology, CHU Lille, Lille, FranceDepartment of Dermatology, Charité Hospital, Berlin, GermanyDepartment of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France; INSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, FranceINSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, France; Department of Biostatistics, Saint-Louis Hospital, AP-HP, Paris, FranceDepartment of Biostatistics, Saint-Louis Hospital, AP-HP, Paris, FranceINSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, France; Department of Biostatistics, Saint-Louis Hospital, AP-HP, Paris, FranceDepartment of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France; INSERM U976, Institut de Recherche Saint-Louis, Paris, France; Université Paris Cité, Paris, France; Corresponding author. Department of Dermatology, National Reference Center for Cutaneous Lymphomas, Saint-Louis Hospital, 1 avenue Claude Vellefaux, F-75010, Paris, France.http://www.sciencedirect.com/science/article/pii/S2589537024005583 |
spellingShingle | Alizée Bozonnat Marie Beylot-Barry Olivier Dereure Michel D’Incan Gaëlle Quereux Emmanuella Guenova Marie Perier-Muzet Stephane Dalle Florent Grange Manuelle-Anne Viguier Caroline Ram-Wolff Laurence Feldmeyer Helmut Beltraminelli Nathalie Bonnet Florent Amatore Eve Maubec Nathalie Franck Laurent Machet François Chasset Florence Brunet-Possenti Jean-David Bouaziz Maxime Battistella Marie Donzel Anne Pham-Ledard Claudia Bejar Hélène Moins-Teisserenc Samia Mourah Philippe Saiag Ewa Hainaut Catherine Michel Guido Bens Henri Adamski François Aubin Serge Boulinguez Pascal Joly Billal Tedbirt Isabelle Templier Laura Troin Henri Montaudié Saskia Ingen-Housz-Oro Sarah Faiz Laurent Mortier Gabor Dobos Martine Bagot Matthieu Resche-Rigon Claire Montlahuc Arnaud Serret-Larmande Adèle de Masson Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study EClinicalMedicine |
title | Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study |
title_full | Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study |
title_fullStr | Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study |
title_full_unstemmed | Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study |
title_short | Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study |
title_sort | real life efficacy of immunotherapy for sezary syndrome a multicenter observational cohort study |
url | http://www.sciencedirect.com/science/article/pii/S2589537024005583 |
work_keys_str_mv | AT alizeebozonnat reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT mariebeylotbarry reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT olivierdereure reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT micheldincan reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT gaellequereux reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT emmanuellaguenova reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT marieperiermuzet reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT stephanedalle reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT florentgrange reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT manuelleanneviguier reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT carolineramwolff reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT laurencefeldmeyer reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT helmutbeltraminelli reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT nathaliebonnet reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT florentamatore reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT evemaubec reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT nathaliefranck reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT laurentmachet reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT francoischasset reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT florencebrunetpossenti reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT jeandavidbouaziz reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT maximebattistella reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT mariedonzel reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT annephamledard reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT claudiabejar reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT helenemoinsteisserenc reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT samiamourah reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT philippesaiag reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT ewahainaut reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT catherinemichel reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT guidobens reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT henriadamski reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT francoisaubin reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT sergeboulinguez reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT pascaljoly reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT billaltedbirt reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT isabelletemplier reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT lauratroin reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT henrimontaudie reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT saskiaingenhouszoro reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT sarahfaiz reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT laurentmortier reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT gabordobos reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT martinebagot reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT matthieurescherigon reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT clairemontlahuc reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT arnaudserretlarmande reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy AT adeledemasson reallifeefficacyofimmunotherapyforsezarysyndromeamulticenterobservationalcohortstudy |